| Andrew C Westfall, MD | |
|
2450 12th Street Se, Salem, OR 97302 | |
| (503) 371-4350 | |
| (503) 371-1124 |
| Full Name | Andrew C Westfall |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 2450 12th Street Se, Salem, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003989781 | NPI | - | NPPES |
| 048239003 | Other | OREGON BLUE CROSS | |
| 213738 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | NB26000 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salem Hospital | Salem, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Consultants, Llc | 0941271886 | 4 |
News Archive
The AACR Annual Meeting 2013 will bring more than 17,000 scientists, advocates, industry leaders and other professionals to Washington, D.C., for the latest in breakthrough cancer science.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
Clinical trials of pre-exposure prophylaxis - that is giving anti-retroviral drugs to non-HIV-infected individuals to prevent them becoming infected - are exploring whether the approach could lead to a large decrease in transmission of the virus with few or no side effects.
Researchers and advocates from the Pancreatic Cancer Action Network will join nearly 200 national organizations today in demonstrating their concern about the impact of sequestration on cancer research during the Rally for Medical Research at 11 AM on the steps of the Carnegie Library in Washington, D.C.
Expanding the age of eligibility for measles vaccination from 12 to 15 months could have potentially large effects on coverage in Africa, according to a new report published by Princeton University's Woodrow Wilson School of Public and International Affairs.
› Verified 6 days ago
| Entity Name | Retina Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528181674 PECOS PAC ID: 0941271886 Enrollment ID: O20040804000160 |
News Archive
The AACR Annual Meeting 2013 will bring more than 17,000 scientists, advocates, industry leaders and other professionals to Washington, D.C., for the latest in breakthrough cancer science.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
Clinical trials of pre-exposure prophylaxis - that is giving anti-retroviral drugs to non-HIV-infected individuals to prevent them becoming infected - are exploring whether the approach could lead to a large decrease in transmission of the virus with few or no side effects.
Researchers and advocates from the Pancreatic Cancer Action Network will join nearly 200 national organizations today in demonstrating their concern about the impact of sequestration on cancer research during the Rally for Medical Research at 11 AM on the steps of the Carnegie Library in Washington, D.C.
Expanding the age of eligibility for measles vaccination from 12 to 15 months could have potentially large effects on coverage in Africa, according to a new report published by Princeton University's Woodrow Wilson School of Public and International Affairs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew C Westfall, MD 2450 12th Street Se, Salem, OR 97302 Ph: (503) 371-4350 | Andrew C Westfall, MD 2450 12th Street Se, Salem, OR 97302 Ph: (503) 371-4350 |
News Archive
The AACR Annual Meeting 2013 will bring more than 17,000 scientists, advocates, industry leaders and other professionals to Washington, D.C., for the latest in breakthrough cancer science.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
Clinical trials of pre-exposure prophylaxis - that is giving anti-retroviral drugs to non-HIV-infected individuals to prevent them becoming infected - are exploring whether the approach could lead to a large decrease in transmission of the virus with few or no side effects.
Researchers and advocates from the Pancreatic Cancer Action Network will join nearly 200 national organizations today in demonstrating their concern about the impact of sequestration on cancer research during the Rally for Medical Research at 11 AM on the steps of the Carnegie Library in Washington, D.C.
Expanding the age of eligibility for measles vaccination from 12 to 15 months could have potentially large effects on coverage in Africa, according to a new report published by Princeton University's Woodrow Wilson School of Public and International Affairs.
› Verified 6 days ago
Dr. Scott Michael Mcclintic, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2450 12th St Se, Salem, OR 97302 Phone: 503-371-4350 Fax: 503-371-1124 | |
Ryan W Lapour, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 Medical Center Dr Ne, Salem, OR 97301 Phone: 503-581-5287 Fax: 503-588-6843 | |
Marcus Allan East, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 Medical Center Dr Ne, Salem, OR 97301 Phone: 503-581-5287 Fax: 503-588-6843 | |
John G Dodd, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 Medical Center Dr Ne, Salem, OR 97301 Phone: 503-581-5287 Fax: 503-588-6843 | |
Dr. Chad Max Bingham, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1285 Liberty St Se, Salem, OR 97302 Phone: 503-585-2022 Fax: 503-365-3832 | |
Dr. Richard Coleman Lieurance, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-361-5400 |